Literature DB >> 4703233

Evidence for a postsecretory reabsorptive site for uric acid in man.

H S Diamond, J S Paolino.   

Abstract

The effects of administration of drug combinations on uric acid excretion were studied in order to test the hypothesis that a portion of renal tubular reabsorption of uric acid occurs distal to the uric acid secretory site. Oral administration of pyrazinamide (3 g) during probenecid uricosuria (probenecid 500 mg every 6 h) decreased urate excretion from 463 mug/min following probenecid medication alone to 135 mug/min following probenecid plus pyrazinamide (P < 0.01). When a greater uricosuric effect was induced with a 2 g oral dose of probenecid, the decrement in urate excretion which followed pyrazinamide administration (3 g) was more pronounced (2,528 mug/min following probenecid alone, 574 mug/min following probenecid plus pyrazinamide). Results were similar when an 800 mg oral dose of sulfinpyrazone was given in place of probenecid (1,885 mug/min following sulfinpyrazone alone, 475 mug/min following sulfinpyrazone plus pyrazinamide). Thus, apparent urate secretion (measured as the decrease in excretion of urinary uric acid resulting from pyrazinamide administration) appeared to vary, depending upon the degree of inhibition of reabsorption produced by probenecid or sulfinpyrazone. When small doses of aspirin were administered in place of pyrazinamide to produce secretory inhibition, the results were similar. Neither probenecid nor pyrazinamide significantly altered urate excretion when administered to patients with serum salicylate levels above 14 mg/100 ml. These results are interpreted as suggesting that renal tubular reabsorption of uric acid occurs at least in part at a postsecretory site and that a portion of secreted urate is reabsorbed. During maximum probenecid- or sulfinpyrazone-induced uricosuria, inhibition of urate secretion with either pyrazinamide or low doses of aspirin resulted in a decrease in uric acid excretion which exceeded total urinary uric acid during control periods by two- to fourfold. This suggests that renal tubular secretion of urate may greatly exceed uric acid excretion and that a large fraction of secreted urate is reabsorbed. The pyrazinamide suppression test underestimates urate secretion. Uricosuria induced by some drugs, including probenecid, sulfinpyrazone, and iodinated radioopaque dyes, appears to represent, at least in part, inhibition of postsecretory urate reabsorption.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4703233      PMCID: PMC302414          DOI: 10.1172/JCI107323

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors:  T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Tubular secretion of urate in man.

Authors:  A B GUTMAN; T F YU; L BERGER
Journal:  J Clin Invest       Date:  1959-10       Impact factor: 14.808

3.  A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.

Authors:  J J BURNS; T F YU; A RITTERBAND; J M PEREL; A B GUTMAN; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1957-03       Impact factor: 4.030

4.  Effect of sodium lactate infusion on urate clearance in man.

Authors:  T F YU; J H SIROTA; L BERGER; M HALPERN; A B GUTMAN
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

5.  Effect of urine flow rate on uric acid excretion in man.

Authors:  H S Diamond; R Lazarus; D Kaplan; D Halberstam
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

6.  Hypouricemia in Hodgkin's disease.

Authors:  J S Bennett; J Bond; I Singer; A J Gottlieb
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

7.  Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid).

Authors:  A B Gutman; T F Yü; L Berger
Journal:  Am J Med       Date:  1969-10       Impact factor: 4.965

8.  Binding of urate to proteins of human and rabbit plasma.

Authors:  M I Sheikh; J V Moller
Journal:  Biochim Biophys Acta       Date:  1968-06-24

9.  Automated analysis of uric acid.

Authors:  L V Crowley; F I Alton
Journal:  Am J Clin Pathol       Date:  1968-02       Impact factor: 2.493

10.  Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.

Authors:  R Bluestone; I Kippen; J R Klinenberg; M W Whitehouse
Journal:  J Lab Clin Med       Date:  1970-07
View more
  20 in total

Review 1.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

2.  Urate excretion and urine flow in a lithium-induced diabetes insipidus rat model.

Authors:  T H Steele; J L Underwood; K L Dudgeon
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

3.  Changes in renal function induced by endralazine, a new antihypertensive drug.

Authors:  E Wegmüller; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

5.  Influence of volume expansion, serum sodium, and fractional excretion of sodium on urate excretion.

Authors:  H Diamond; A Meisel
Journal:  Pflugers Arch       Date:  1975-04-09       Impact factor: 3.657

6.  Influence of urate-lowering therapies on renal handling of uric acid.

Authors:  Lili Ma; Lei Wei; Huiyong Chen; Zhuojun Zhang; Qiang Yu; Zongfei Ji; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

7.  Drug interactions with urate excretion in man.

Authors:  D K Sommers; H S Schoeman
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism.

Authors:  T Gibson; H P Sims; S A Jimenez
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

9.  Effect of combined administration of furosemide and aspirin on urinary urate excretion in man.

Authors:  T Mountokalakis; D Rallis; D Mayopoulou-Symvoulidou; Z Komninos
Journal:  Klin Wochenschr       Date:  1979-12-03

10.  Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease.

Authors:  Sezin Yakut; Zafer Cetin; Mehmet Arman; Halide Akbas; Ayse E Manguoglu; Guven Luleci
Journal:  Rheumatol Int       Date:  2012-11-06       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.